glipizide and chlorpropamide

glipizide has been researched along with chlorpropamide in 39 studies

Research

Studies (39)

TimeframeStudies, this research(%)All Research%
pre-199016 (41.03)18.7374
1990's9 (23.08)18.2507
2000's7 (17.95)29.6817
2010's6 (15.38)24.3611
2020's1 (2.56)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Gozalbes, R; Pineda-Lucena, A1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Melander, A; Wåhlin-Boll, E2
Balant, L1
Bandisode, MS; Boshell, BR1
Müller, WE; Wollert, U1
Madhavan, R; Sankaran, JR; Seshasaianam, C; Seshiah, V; Shanker, R; Sundaram, A; Venkataraman, S1
Harrower, AD2
Boutagy, JS; Shenfield, GM; Webb, C1
Barclay, SC; Gibson, J; Lamey, PJ; Miller, S1
Cabello, MA; Felíu, JE; Monge, L; Ortega, JL; Samper, B1
Morrison, AD; Shank, WA1
Almér, LO1
Hellman, B; Sehlin, J; Täljedal, IB1
Arranto, AJ; Keinänen, K; Kerola, T; Saarni, HU; Sotaniemi, EA; Stengård, JH; Sutinen, S1
Alberetto, M; Baio, G; Bertoletti, A; Pontiroli, AE; Pozza, G1
Melander, A; Sartor, G; Scherstén, B; Wåhlin-Boll, E3
Almér, LO; Johansson, E; Melander, A; Wåhlin-Boll, E1
Elliott, BD; Johnson, R; Langer, O; Prihoda, T; Schenker, S1
Selvaag, E1
Abenhaim, L; Monette, J; van Staa, T1
André, P1
Galli Kienle, M; Magni, F; Marazzini, L; Monti, L; Pereira, S1
Gottsäter, M; Lindberg, G; Lindwall, K; Melander, A; Olsson, J; Tisell, A1
Jannetto, PJ; Langman, LJ1

Reviews

3 review(s) available for glipizide and chlorpropamide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
["First" and "second" generation sulfonylureas: distinction or difference? (author's transl)].
    Diabete & metabolisme, 1978, Volume: 4, Issue:2

    Topics: Animals; Chlorpropamide; Dose-Response Relationship, Drug; Glipizide; Glyburide; Half-Life; Humans; Hypoglycemic Agents; Kinetics; Structure-Activity Relationship; Sulfonylurea Compounds; Tolbutamide

1978
Oral sulfonylureas for the treatment of type II diabetes: an update.
    Southern medical journal, 1986, Volume: 79, Issue:3

    Topics: Administration, Oral; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Hypersensitivity; Glipizide; Glyburide; Humans; Insulin Resistance; Kinetics; Liver; Nausea; Patient Education as Topic; Sulfonylurea Compounds

1986

Trials

4 trial(s) available for glipizide and chlorpropamide

ArticleYear
Clinical evaluation of a new sulfonylurea in maturity onset diabetes - glipizide (K-4024).
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1976, Volume: 8, Issue:2

    Topics: Adult; Aged; Chlorpropamide; Clinical Trials as Topic; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Follow-Up Studies; Glipizide; Humans; Middle Aged; Phenformin; Sulfonylurea Compounds; Tolbutamide

1976
Efficacy of gliclazide in comparison with other sulphonylureas in the treatment of NIDDM.
    Diabetes research and clinical practice, 1991, Volume: 14 Suppl 2

    Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diet, Diabetic; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Tolbutamide

1991
Comparison of diabetic control in type 2 (non-insulin dependent) diabetic patients treated with different sulphonylureas.
    Current medical research and opinion, 1985, Volume: 9, Issue:10

    Topics: Aged; Chlorpropamide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Middle Aged; Random Allocation; Sulfonylurea Compounds

1985
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet (London, England), 1998, Sep-12, Volume: 352, Issue:9131

    Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Prospective Studies; Risk Factors; Sulfonylurea Compounds

1998

Other Studies

32 other study(ies) available for glipizide and chlorpropamide

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Molecular characteristics for solid-state limited solubility.
    Journal of medicinal chemistry, 2008, May-22, Volume: 51, Issue:10

    Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility

2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
QSAR-based solubility model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2010, Oct-01, Volume: 18, Issue:19

    Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
High-performance liquid chromatographic determination of glipizide and some other sulfonylurea drugs in serum.
    Journal of chromatography, 1979, Dec-01, Volume: 164, Issue:4

    Topics: Chlorpropamide; Chromatography, High Pressure Liquid; Glipizide; Glyburide; Humans; Hydrogen-Ion Concentration; Sulfonylurea Compounds; Tolbutamide

1979
Circular dichroism studies on the interaction of sulfonylureas with bovine and human serum albumin.
    Research communications in chemical pathology and pharmacology, 1976, Volume: 13, Issue:3

    Topics: Binding Sites; Binding, Competitive; Carbutamide; Chlorpropamide; Circular Dichroism; Glipizide; Glyburide; Humans; In Vitro Techniques; Optical Rotatory Dispersion; Protein Binding; Serum Albumin; Serum Albumin, Bovine; Sulfonylurea Compounds; Tolbutamide

1976
Effect of bed time intermediate acting insulin in NIDDM subjects refractory to a combination of sulphonylureas and biguanides.
    The Journal of the Association of Physicians of India, 1992, Volume: 40, Issue:10

    Topics: Biguanides; Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Injections, Subcutaneous; Insulin, Long-Acting; Lipids; Male; Metformin; Middle Aged; Phenformin; Sulfonylurea Compounds; Time Factors

1992
A screening test for detecting sulfonylureas in plasma.
    Therapeutic drug monitoring, 1990, Volume: 12, Issue:4

    Topics: Aged; Aged, 80 and over; Chlorpropamide; Chromatography, High Pressure Liquid; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemia; Male; Middle Aged; Sulfonylurea Compounds; Tolbutamide

1990
Grinspan's syndrome: a drug-induced phenomenon?
    Oral surgery, oral medicine, and oral pathology, 1990, Volume: 70, Issue:2

    Topics: Aged; Aged, 80 and over; Atenolol; Bendroflumethiazide; Chlorpropamide; Diabetes Mellitus, Type 2; Drug Hypersensitivity; Female; Furosemide; Glipizide; Humans; Hypertension; Lichen Planus; Metformin; Middle Aged; Mouth Diseases; Spironolactone; Syndrome

1990
Effect of glipizide on hepatic fructose 2,6-bisphosphate concentration and glucose metabolism.
    Metabolism: clinical and experimental, 1987, Volume: 36, Issue:8

    Topics: Animals; Chlorpropamide; Cyclic AMP; Fructosediphosphates; Glipizide; Gluconeogenesis; Glucose; Hexosediphosphates; Hexosephosphates; In Vitro Techniques; Lactates; Liver; Male; Rats; Rats, Inbred Strains; Sulfonylurea Compounds; Tolbutamide

1987
Vascular fibrinolytic activity in long term treatment with second generation sulfonylurea compounds.
    Acta endocrinologica. Supplementum, 1980, Volume: 239

    Topics: alpha-Macroglobulins; Blood Vessels; Chlorpropamide; Diabetes Mellitus; Endothelium; Fibrinolysis; Gliclazide; Glipizide; Humans; Plasminogen Activators; Plasminogen Inactivators; Sulfonylurea Compounds

1980
Glibenclamide is exceptional among hypoglycaemic sulphonylureas in accumulating progressively in beta-cell-rich pancreatic islets.
    Acta endocrinologica, 1984, Volume: 105, Issue:3

    Topics: Animals; Carbutamide; Chlorpropamide; Glipizide; Glyburide; Islets of Langerhans; Mice; Mice, Obese; Sulfonylurea Compounds; Tolbutamide

1984
Hepatic glucose-6-phosphatase activity in non-insulin dependent diabetics. Effect of enzyme-inducing drugs.
    Acta medica Scandinavica, 1984, Volume: 215, Issue:4

    Topics: Aged; Antipyrine; Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Enzyme Induction; Female; Glipizide; Glucose-6-Phosphatase; Humans; Liver; Liver Glycogen; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Microsomes, Liver; Middle Aged; Phenobarbital

1984
Sulfonylureas enhance in vivo the effectiveness of insulin in type 1 (insulin dependent) diabetes mellitus.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1984, Volume: 16 Suppl 1

    Topics: Adolescent; Adult; Chlorpropamide; Diabetes Mellitus, Type 1; Drug Interactions; Female; Glipizide; Humans; Insulin; Male; Sulfonylurea Compounds; Tolbutamide

1984
Clinical pharmacology of glipizide.
    The American journal of medicine, 1983, Nov-30, Volume: 75, Issue:5B

    Topics: Biological Availability; Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Glipizide; Glyburide; Half-Life; Humans; Kinetics; Structure-Activity Relationship; Sulfonylurea Compounds; Tolbutamide

1983
Kinetics-effect relations of glipizide and other sulfonylureas.
    Acta endocrinologica. Supplementum, 1980, Volume: 239

    Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus; Dose-Response Relationship, Drug; Fasting; Feeding Behavior; Glipizide; Glyburide; Humans; Kidney; Sulfonylurea Compounds; Tolbutamide

1980
Comparative single-dose kinetics and effects of four sulfonylureas in healthy volunteers.
    Acta medica Scandinavica, 1980, Volume: 208, Issue:4

    Topics: Adult; Blood Glucose; Chlorpropamide; Fasting; Glipizide; Glyburide; Humans; Insulin; Kinetics; Male; Sulfonylurea Compounds; Time Factors; Tolbutamide

1980
Impaired effect of sulfonylurea following increased dosage.
    European journal of clinical pharmacology, 1982, Volume: 22, Issue:1

    Topics: Aged; Blood Glucose; Body Weight; Chlorpropamide; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Food; Glipizide; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Sulfonylurea Compounds

1982
Influence of sulfonylureas on the secretion, disposal and effect of insulin.
    European journal of clinical pharmacology, 1982, Volume: 22, Issue:1

    Topics: Aged; Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus; Female; Glipizide; Half-Life; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Sulfonylurea Compounds

1982
Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer.
    American journal of obstetrics and gynecology, 1994, Volume: 171, Issue:3

    Topics: Administration, Oral; Analysis of Variance; Antipyrine; Biological Transport; Chlorpropamide; Chromatography, High Pressure Liquid; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Maternal-Fetal Exchange; Models, Biological; Molecular Weight; Placenta; Pregnancy; Regression Analysis; Tolbutamide

1994
Photohemolytic potency of oral antidiabetic drugs in vitro: effects of antioxidants and a nitrogen atmosphere.
    Photodermatology, photoimmunology & photomedicine, 1996, Volume: 12, Issue:4

    Topics: Antioxidants; Ascorbic Acid; Carbutamide; Chlorpropamide; Dose-Response Relationship, Drug; Gliclazide; Glipizide; Glyburide; Hemolysis; Humans; Hypoglycemic Agents; Nitrogen; Radiation-Sensitizing Agents; Reactive Oxygen Species; Sulfonamides; Sulfonylurea Compounds; Superoxide Dismutase; Tolazamide; Tolbutamide; Ultraviolet Rays; Vitamin E

1996
Rates of hypoglycemia in users of sulfonylureas.
    Journal of clinical epidemiology, 1997, Volume: 50, Issue:6

    Topics: Adult; Aged; Chlorpropamide; Female; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Incidence; Male; Middle Aged; Poisson Distribution; Risk; Risk Factors; Sulfonylurea Compounds; Surveys and Questionnaires; Time Factors; Tolbutamide

1997
[Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
    Revue d'epidemiologie et de sante publique, 1999, Volume: 47, Issue:1

    Topics: Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Insulin; Metformin; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Risk Factors

1999
Identification of sulfonylureas in serum by electrospray mass spectrometry.
    Analytical biochemistry, 2000, Jun-15, Volume: 282, Issue:1

    Topics: Calibration; Chlorpropamide; Chromatography, Liquid; Glipizide; Glyburide; Humans; Mass Spectrometry; Models, Chemical; Sulfonylurea Compounds; Tolbutamide; Ultraviolet Rays

2000
Differences in pharmacotherapy and in glucose control of type 2 diabetes patients in two neighbouring towns: a longitudinal population-based study.
    Diabetes, obesity & metabolism, 2001, Volume: 3, Issue:4

    Topics: Aged; Blood Glucose; Chlorpropamide; Diabetes Mellitus, Type 2; Female; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Longitudinal Studies; Male; Retrospective Studies; Sweden; Time Factors; Urban Population

2001
Analysis of Hypoglycemic Drugs by Liquid Chromatography-Tandem Mass Spectrometry.
    Methods in molecular biology (Clifton, N.J.), 2024, Volume: 2737

    Topics: Chlorpropamide; Chromatography, High Pressure Liquid; Chromatography, Liquid; Glipizide; Glyburide; Humans; Hypoglycemic Agents; Nateglinide; Pioglitazone; Rosiglitazone; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tolazamide; Tolbutamide

2024